Yotaro Nishikawa

5PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical microbiology not elsewhere classifiedHaematological tumoursAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 06, 2025
Maximum Standard Uptake Value of Pre-Therapeutic 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Outcomes in Indolent Adult T-Cell Leukemia/Lymphoma Patients With Cutaneous Involvement.

Kyoko Nogami, Yotaro Nishikawa, Kosuke Mochida

|Jul 11, 2023
Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity.

Tomofumi Uto, Tomohiro Fukaya, Shuya Mitoma

|Jul 05, 2022
T-cell prolymphocytic leukemia with follicular mucinosis.

Rieko Nemoto, Yotaro Nishikawa, Kosuke Mochida

|Feb 09, 2021
Adult T-cell leukemia/lymphoma with pagetoid reticulosis-like skin lesions.

Yotaro Nishikawa, Shiho Kanemaru, Aina Mori

|May 22, 2019
Smoldering type adult T-cell leukemia/lymphoma effectively treated with mogamulizumab (anti-CC chemokine receptor 4 monoclonal antibody)-A case report.

Yotaro Nishikawa, Kosuke Mochida, Tamaki Kubo

Pageof 1

Frequent Collaborators

1 joint publications

Tomofumi Uto

1 joint publications

Tomohiro Fukaya

1 joint publications

Shuya Mitoma

1 joint publications

Moe Tominaga